Involvement of gonadotropins in induction of luteolysis in pigs.
In our previous study we have demonstrated that treatment of endometrial explants with LH increased 13,14-dihydro-15-ketoprostaglandin F(2alpha) (PGFM) accumulation in pigs. This was particularly visible on Days 14-16 of the estrous cycle. Action of gonadotropin in porcine endometrium appears to be mediated by LH/hCG receptors whose number is dependent on the day of the estrous cycle. In the current study i.v. infusion (1 hour) of hCG (200 IU) performed on Days 10 (n=4) and 12-14 (n=4) of the porcine estrous cycle did not affect plasma PGFM (ng/ml+/-SEM) concentrations. In contrast, administration of hCG on Days 15-17 produced, depending on plasma PGFM level before the infusion period, three different types of response: I. plasma PGFM surge of amplitude 0.62+/-0.15 was observed when the mean basal pre-infusion PGFM plasma level was 0.23+/-0.05 (n=6 gilts); II. the delayed PGFM surge of amplitude 0.62+/-0.15 was determined when basal pre-infusion PGFM level was 0.80+/-0.20 (n=6); and III. lack of PGFM response to hCG was found when basal pre-infusion PGFM level was 1.09+/-0.61 (n=6). Concentrations of plasma PGFM before and after saline infusion did not differ on Days 12-14 and 16 of the estrous cycle. In the next experiment blood samples were collected every 1 hour on Days 12-19 of the estrous cycle to determine concentrations of LH, PGFM and progesterone in four gilts. In particular gilts, plasma peaks of LH closely preceded surges of PGFM in 72.7, 84.6, 75.0 and 66.6 percent, respectively. The highest PGFM surges followed a decline in plasma progesterone concentration. We conclude that the increased PGF(2alpha) metabolite production after hCG infusion during the late luteal phase of the estrous cycle as well as the relationship between plasma LH and PGFM peaks suggest the LH involvement in the elevation of endometrial PGF(2alpha) secretion in pigs, and, in consequence, induction of luteolysis.
Ziecik
A J
AJ
Institute of Animal Reproduction and Food Research of Polish Academy of Sciences, 10-747 Olsztyn, ul. Tuwima 10, Poland. ziecik@pan.olsztyn.pl
Kotwica
G
G
D000818:Animals; D006063:Chorionic Gonadotropin / Q000008:administration & dosage; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism; D030762:Estrous Cycle; D005260:Female; D006062:Gonadotropins / Q000502:physiology*; D007986:Luteinizing Hormone / Q000097:blood; D003341:Luteolysis / Q000502:physiology*; D010507:Periodicity; D011374:Progesterone / Q000097:blood; D011974:Receptors, LH / Q000502:physiology; D012680:Sensitivity and Specificity; D013552:Swine / Q000502:physiology*
D006063:Chorionic Gonadotropin; D006062:Gonadotropins; D011974:Receptors, LH; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D011374:Progesterone; D007986:Luteinizing Hormone; D015237:Dinoprost